Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of OncoTherapy Science, Inc. patents

Patents where

Current Assignee

Name

OncoTherapy Science, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9284349 Peptide vaccines for cancers expressing tumor-associated antigens	Patent 9284349 was granted and assigned to OncoTherapy Science, Inc. on March, 2016 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9284349	March 15, 2016
‌ US Patent 11547723 KOC1-derived peptide and vaccine including same	Patent 11547723 was granted and assigned to OncoTherapy Science, Inc. on January, 2023 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	11547723	January 10, 2023
‌ US Patent 7919099 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides	Patent 7919099 was granted and assigned to OncoTherapy Science, Inc. on April, 2011 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7919099	April 5, 2011
‌ US Patent 7521205 Genes and polypeptides relating to prostate cancers	Patent 7521205 was granted and assigned to OncoTherapy Science, Inc. on April, 2009 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7521205	April 21, 2009
‌ US Patent 7569351 P53 dependent apoptosis-associated gene and protein	Patent 7569351 was granted and assigned to OncoTherapy Science, Inc. on August, 2009 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7569351	August 4, 2009
‌ US Patent 7425612 Genes and polypeptides relating to human colon cancers	Patent 7425612 was granted and assigned to OncoTherapy Science, Inc. on September, 2008 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7425612	September 16, 2008
‌ US Patent 7700573 Method for diagnosing non-small lung cancer	Patent 7700573 was granted and assigned to OncoTherapy Science, Inc. on April, 2010 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7700573	April 20, 2010
‌ US Patent 7601826 Genes and polypeptides relating to human pancreatic cancers	Patent 7601826 was granted and assigned to OncoTherapy Science, Inc. on October, 2009 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7601826	October 13, 2009
‌ US Patent 7972772 KIF11 and method for diagnosing non-small cell lung cancer	Patent 7972772 was granted and assigned to OncoTherapy Science, Inc. on July, 2011 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	7972772	July 5, 2011
‌ US Patent 8962648 Tricyclic compounds and PBK inhibitors containing the same	Patent 8962648 was granted and assigned to OncoTherapy Science, Inc. on February, 2015 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	8962648	February 24, 2015
‌ US Patent 9017669 Anti-CDH3 antibodies and uses thereof	Patent 9017669 was granted and assigned to OncoTherapy Science, Inc. on April, 2015 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	9017669	April 28, 2015
‌ US Patent 9345709 1,5-naphthyridine derivatives and MELK inhibitors containing the same	Patent 9345709 was granted and assigned to OncoTherapy Science, Inc. on May, 2016 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9345709	May 24, 2016
‌ US Patent 9446106 NEIL3 peptides and vaccines including the same	Patent 9446106 was granted and assigned to OncoTherapy Science, Inc. on September, 2016 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9446106	September 20, 2016
‌ US Patent 8435749 Anti-CDH3 antibodies labeled with radioisotope label and uses thereof	Patent 8435749 was granted and assigned to OncoTherapy Science, Inc. on May, 2013 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	8435749	May 7, 2013
‌ US Patent 9585948 TOMM34 peptides and vaccines including the same	Patent 9585948 was granted and assigned to OncoTherapy Science, Inc. on March, 2017 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9585948	March 7, 2017
‌ US Patent 9427461 TOPK peptides and vaccines including the same	Patent 9427461 was granted and assigned to OncoTherapy Science, Inc. on August, 2016 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9427461	August 30, 2016
‌ US Patent 8003098 Methods for damaging cells using effector functions of anti-EphA4 antibodies	Patent 8003098 was granted and assigned to OncoTherapy Science, Inc. on August, 2011 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	8003098	August 23, 2011
‌ US Patent 9045557 NEIL3 peptides and vaccines including the same	Patent 9045557 was granted and assigned to OncoTherapy Science, Inc. on June, 2015 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	9045557	June 2, 2015
‌ US Patent 9403890 HJURP peptides and vaccines including the same	Patent 9403890 was granted and assigned to OncoTherapy Science, Inc. on August, 2016 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9403890	August 2, 2016
‌ US Patent 9975935 NEIL3 peptides and vaccines including the same	Patent 9975935 was granted and assigned to OncoTherapy Science, Inc. on May, 2018 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9975935	May 22, 2018
‌ US Patent 9849166 TOPK peptides and vaccines including the same	Patent 9849166 was granted and assigned to OncoTherapy Science, Inc. on December, 2017 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9849166	December 26, 2017
‌ US Patent 9896492 HJURP peptides and vaccines including the same	Patent 9896492 was granted and assigned to OncoTherapy Science, Inc. on February, 2018 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9896492	February 20, 2018
‌ US Patent 9597382 KNTC2 peptides and vaccines containing the same	Patent 9597382 was granted and assigned to OncoTherapy Science, Inc. on March, 2017 by the United States Patent and Trademark Office.	OncoTherapy Science, Inc.	OncoTherapy Science, Inc.	United States Patent and Trademark Office	9597382	March 21, 2017
‌ US Patent 9458447 MPHOSPH1 peptides and vaccines including the same	Patent 9458447 was granted and assigned to OncoTherapy Science, Inc. on October, 2016 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	9458447	October 4, 2016
‌ US Patent 8951975 ECT2 peptides and vaccines including the same	Patent 8951975 was granted and assigned to OncoTherapy Science, Inc. on February, 2015 by the United States Patent and Trademark Office.		OncoTherapy Science, Inc.	United States Patent and Trademark Office	8951975	February 10, 2015

...

Results per page:

125 results

0 selected

125 results

0 selected